{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:31:49Z","timestamp":1794439909325,"version":"4.9.1"},"reference-count":202,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000732","name":"UK-India Education and Research Initiative","doi-asserted-by":"publisher","award":["UKIERI-SPARC\/01\/07"],"award-info":[{"award-number":["UKIERI-SPARC\/01\/07"]}],"id":[{"id":"10.13039\/501100000732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004541","name":"Ministry of Education, India","doi-asserted-by":"publisher","award":["P3345"],"award-info":[{"award-number":["P3345"]}],"id":[{"id":"10.13039\/501100004541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004541","name":"Ministry of Education, India","doi-asserted-by":"publisher","award":["P4008"],"award-info":[{"award-number":["P4008"]}],"id":[{"id":"10.13039\/501100004541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019550","name":"SPARC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"India Ministry of Science & Technology Department of Biotechnology","doi-asserted-by":"publisher","award":["BT\/PR47642\/CMD\/150\/24\/2023"],"award-info":[{"award-number":["BT\/PR47642\/CMD\/150\/24\/2023"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejmech.2026.118781","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:03:38Z","timestamp":1773680618000},"page":"118781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["COX-2 inhibitors in inflammation and cancer: Recent developments in medicinal chemistry"],"prefix":"10.1016","volume":"310","author":[{"family":"Chahat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3362-7558","authenticated-orcid":false,"given":"Muhammad","family":"Wahajuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupinder","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejmech.2026.118781_bib1","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs","volume":"9","author":"Chen","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2026.118781_bib2","series-title":"Acute Inflammatory Response","author":"Hannoodee","year":"2020"},{"issue":"3","key":"10.1016\/j.ejmech.2026.118781_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/aam.aam_56_18","article-title":"Inflammation and cancer","volume":"18","author":"Singh","year":"2019","journal-title":"Ann. Afr. Med."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118781_bib4","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrneph.2017.51","article-title":"The immunology of atherosclerosis","volume":"13","author":"Gister\u00e5","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"issue":"7","key":"10.1016\/j.ejmech.2026.118781_bib5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nri3705","article-title":"Innate immune activation in neurodegenerative disease","volume":"14","author":"Heneka","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118781_bib6","first-page":"37","article-title":"Chronic inflammatory systemic diseases: an evolutionary trade-off between acutely beneficial but chronically harmful programs","volume":"2016","author":"Straub","year":"2016","journal-title":"Evol., Med. Public Health"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118781_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118781_bib8","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cmet.2013.05.011","article-title":"Innate immune receptors: key regulators of metabolic disease progression","volume":"17","author":"Jin","year":"2013","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118781_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri.2017.142","article-title":"NF-\u03baB, inflammation, immunity and cancer: coming of age","volume":"18","author":"Taniguchi","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118781_bib10","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"9","key":"10.1016\/j.ejmech.2026.118781_bib11","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/13543776.2024.2373771","article-title":"Selective COX-2 inhibitors as anticancer agents: a patent review (2018-2023)","volume":"34","author":"Mahboubi-Rabbani","year":"2024","journal-title":"Expert Opin. Ther. Pat."},{"issue":"6917","key":"10.1016\/j.ejmech.2026.118781_bib12","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"issue":"9255","key":"10.1016\/j.ejmech.2026.118781_bib13","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejmech.2026.118781_bib14","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrc1046","article-title":"Radical causes of cancer","volume":"3","author":"Hussain","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2026.118781_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jare.2018.03.005","article-title":"Synopsis of arachidonic acid metabolism: a review","volume":"11","author":"Hanna","year":"2018","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ejmech.2026.118781_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2021.106587","article-title":"Licofelone, a potent COX\/5-LOX inhibitor and a novel option for treatment of neurological disorders","volume":"157","author":"Razavi","year":"2021","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.ejmech.2026.118781_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.yjmcc.2018.01.010","article-title":"Defective p27 phosphorylation at serine 10 affects vascular reactivity and increases abdominal aortic aneurysm development via Cox-2 activation","volume":"116","author":"Molina-S\u00e1nchez","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejmech.2026.118781_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110389","article-title":"Combined chemotherapy with cyclooxygenase-2 (COX-2) inhibitors in treating human cancers: recent advancement","volume":"129","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118781_bib19","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00054725-200209000-00007","article-title":"Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid","volume":"8","author":"Bernstein","year":"2002","journal-title":"Inflamm. Bowel Dis."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118781_bib20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1158\/0008-5472.CAN-03-1168","article-title":"Synergy between celecoxib and radiotherapy results from inhibition of cyclooxygenase-2-derived prostaglandin E2, a survival factor for tumor and associated vasculature","volume":"64","author":"Davis","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2026.118781_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10787-009-8049-8","article-title":"Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung","volume":"17","author":"Harris","year":"2009","journal-title":"Inflammopharmacology"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118781_bib22","doi-asserted-by":"crossref","DOI":"10.1615\/CritRevEukarGeneExpr.2013006033","article-title":"Role of cancer-related inflammation in esophageal cancer","volume":"23","author":"Zhang","year":"2013","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"issue":"42","key":"10.1016\/j.ejmech.2026.118781_bib23","doi-asserted-by":"crossref","first-page":"7361","DOI":"10.3748\/wjg.v19.i42.7361","article-title":"Role of cyclooxygenase-2 in gastric cancer development and progression","volume":"19","author":"Cheng","year":"2013","journal-title":"World J. Gastroenterol.: WJG"},{"issue":"31","key":"10.1016\/j.ejmech.2026.118781_bib24","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v20.i31.10729","article-title":"Involvement of eicosanoids in the pathogenesis of pancreatic cancer: the roles of cyclooxygenase-2 and 5-lipoxygenase","volume":"20","author":"Knab","year":"2014","journal-title":"World J. Gastroenterol.: WJG"},{"issue":"5","key":"10.1016\/j.ejmech.2026.118781_bib25","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/CEJ.0000000000000023","article-title":"Inflammation induced by human papillomavirus in cervical cancer and its implication in prevention","volume":"23","author":"Parida","year":"2014","journal-title":"Eur. J. Cancer Prev."},{"issue":"14","key":"10.1016\/j.ejmech.2026.118781_bib26","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.2217\/fon.14.152","article-title":"The role of prostaglandin E2 in renal cell cancer development: future implications for prognosis and therapy","volume":"10","author":"Kaminska","year":"2014","journal-title":"Future Oncol."},{"key":"10.1016\/j.ejmech.2026.118781_bib27","doi-asserted-by":"crossref","first-page":"10997","DOI":"10.1007\/s11033-012-2001-5","article-title":"Systematic review and meta-analysis of COX-2 expression and polymorphisms in prostate cancer","volume":"39","author":"Shao","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ejmech.2026.118781_bib28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-3-0348-0837-8_8","article-title":"The role of inflammation in bladder cancer","author":"Gakis","year":"2014","journal-title":"Inflammation and Cancer"},{"issue":"10","key":"10.1016\/j.ejmech.2026.118781_bib29","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1038\/jid.2014.192","article-title":"Cyclooxygenases: mediators of UV-induced skin cancer and potential targets for prevention","volume":"134","author":"Elmets","year":"2014","journal-title":"J. Invest. Dermatol."},{"issue":"10","key":"10.1016\/j.ejmech.2026.118781_bib30","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1016\/j.oraloncology.2009.03.016","article-title":"An overview on the expression of cyclooxygenase-2 in tumors of the head and neck","volume":"45","author":"Mendes","year":"2009","journal-title":"Oral Oncol."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118781_bib31","first-page":"135","article-title":"The influence of Cox-2 and bioactive lipids on hematological cancers","volume":"2","author":"Ramon","year":"2013","journal-title":"Curr. Antimicrob."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118781_bib32","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1158\/1535-7163.MCT-12-1103","article-title":"Cyclooxygenase-2, epidermal growth factor receptor, and aromatase signaling in inflammation and mesothelioma","volume":"12","author":"Nuvoli","year":"2013","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2026.118781_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr1678","article-title":"Inflammation and breast cancer. Cyclooxygenase\/prostaglandin signaling and breast cancer","volume":"9","author":"Howe","year":"2007","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ejmech.2026.118781_bib34","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nat. New Biol."},{"key":"10.1016\/j.ejmech.2026.118781_bib35","series-title":"Cyclooxygenase-2 (cox-2) and the Inflammogenesis of Cancer. Inflammation in the Pathogenesis of Chronic Diseases: the COX-2 Controversy","first-page":"93","author":"Harris","year":"2007"},{"issue":"2","key":"10.1016\/j.ejmech.2026.118781_bib36","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bbadis.2016.11.005","article-title":"Nrf2 signaling pathway: pivotal roles in inflammation","volume":"1863","author":"Ahmed","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"8","key":"10.1016\/j.ejmech.2026.118781_bib37","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1185\/030079905X56367","article-title":"Update on cyclooxygenase inhibitors: has a third COX isoform entered the fray?","volume":"21","author":"Hersh","year":"2005","journal-title":"Curr. Med. Res. Opin."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118781_bib38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0014-5793(96)00604-7","article-title":"Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation","volume":"390","author":"Beiche","year":"1996","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118781_bib39","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1053\/gast.1997.v112.pm9024292","article-title":"Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice","volume":"112","author":"Mizuno","year":"1997","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.ejmech.2026.118781_bib40","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1124\/mol.54.3.536","article-title":"Constitutive cyclooxygenase-2 expression in healthy human and rabbit gastric mucosa","volume":"54","author":"Zimmermann","year":"1998","journal-title":"Mol. Pharmacol."},{"issue":"12","key":"10.1016\/j.ejmech.2026.118781_bib41","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/70995","article-title":"Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing","volume":"5","author":"Jones","year":"1999","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118781_bib42","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1172\/JCI117620","article-title":"Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction","volume":"94","author":"Harris","year":"1994","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118781_bib43","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1172\/JCI118211","article-title":"Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine","volume":"96","author":"Zembowicz","year":"1995","journal-title":"J. Clin. Investig."},{"issue":"22","key":"10.1016\/j.ejmech.2026.118781_bib44","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.2174\/138161207781368774","article-title":"Mechanisms underlying the cardiovascular effects of COX-inhibition: benefits and risks","volume":"13","author":"Martinez-Gonzalez","year":"2007","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118781_bib45","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0092-8674(00)80402-X","article-title":"Multiple female reproductive failures in cyclooxygenase 2\u2013deficient mice","volume":"91","author":"Lim","year":"1997","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ejmech.2026.118781_bib46","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/cea.12697","article-title":"Cyclooxygenase 2: its regulation, role and impact in airway inflammation","volume":"46","author":"Rumzhum","year":"2016","journal-title":"Clin. Exp. Allergy"},{"issue":"7","key":"10.1016\/j.ejmech.2026.118781_bib47","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1440-1843.2008.01365.x","article-title":"Enhanced levels of prostaglandin E2 and matrix metalloproteinase\u20102 correlate with the severity of airflow limitation in stable COPD","volume":"13","author":"Chen","year":"2008","journal-title":"Respirology"},{"issue":"21","key":"10.1016\/j.ejmech.2026.118781_bib48","doi-asserted-by":"crossref","first-page":"13926","DOI":"10.1073\/pnas.162468699","article-title":"COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic\/antipyretic drugs: cloning, structure, and expression","volume":"99","author":"Chandrasekharan","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7","key":"10.1016\/j.ejmech.2026.118781_bib49","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/jcc.21130","article-title":"A comparative study of the COX\u20101 and COX\u20102 isozymes bound to lipid membranes","volume":"30","author":"Wan","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118781_bib50","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/09629350290000041","article-title":"Cyclooxygenase\u20102 inhibitors: promise or peril?","volume":"11","author":"Mengle-Gaw","year":"2002","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ejmech.2026.118781_bib51","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0090-6980(02)00026-6","article-title":"The structures of prostaglandin endoperoxide H synthases-1 and-2","volume":"68","author":"Garavito","year":"2002","journal-title":"Prostag. Other Lipid Mediat."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118781_bib52","doi-asserted-by":"crossref","DOI":"10.5041\/RMMJ.10426","article-title":"Different chemical structures and physiological\/pathological roles of cyclooxygenases","volume":"12","author":"Faki","year":"2021","journal-title":"Rambam Maimonides medical Journal"},{"issue":"6610","key":"10.1016\/j.ejmech.2026.118781_bib53","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/384644a0","article-title":"Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents","volume":"384","author":"Kurumbail","year":"1996","journal-title":"Nature"},{"issue":"2-3","key":"10.1016\/j.ejmech.2026.118781_bib54","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0929-7855(95)00015-I","article-title":"Prostaglandin endoperoxide synthases-1 and-2","volume":"12","author":"Otto","year":"1995","journal-title":"J. Lipid Mediat. Cell Signal"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118781_bib55","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0005-2760(95)00194-8","article-title":"Prostaglandin synthase 2","volume":"1299","author":"Herschman","year":"1996","journal-title":"Biochim. Biophys. Acta Lipids Lipid. Metabol."},{"key":"10.1016\/j.ejmech.2026.118781_bib56","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0090-6980(02)00029-1","article-title":"Distinct functions of COX-1 and COX-2","volume":"68","author":"Morita","year":"2002","journal-title":"Prostag. Other Lipid Mediat."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118781_bib57","first-page":"591","article-title":"Chemopreventive effects of NSAIDs against colorectal cancer: regulation of apoptosis and mitosis by COX-1 and COX-2","volume":"13","author":"Watson","year":"1998","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.ejmech.2026.118781_bib58","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0090-6980(02)00024-2","article-title":"Cyclooxygenase isozymes and their gene structures and expression","volume":"68","author":"Tanabe","year":"2002","journal-title":"Prostag. Other Lipid Mediat."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118781_bib59","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1432-1033.1994.tb18804.x","article-title":"Characterization of the human gene (PTGS2) encoding prostaglandin\u2010endoperoxide synthase 2","volume":"221","author":"Kosaka","year":"1994","journal-title":"Eur. J. Biochem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118781_bib60","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","article-title":"Cyclooxygenases 1 and 2","volume":"38","author":"Vane","year":"1998","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118781_bib61","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","article-title":"Cyclooxygenases: structural, cellular, and molecular biology","volume":"69","author":"Smith","year":"2000","journal-title":"Annu. Rev. Biochem."},{"issue":"46","key":"10.1016\/j.ejmech.2026.118781_bib62","doi-asserted-by":"crossref","first-page":"45763","DOI":"10.1074\/jbc.M305481200","article-title":"A novel mechanism of cyclooxygenase-2 inhibition involving interactions with Ser-530 and Tyr-385","volume":"278","author":"Rowlinson","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118781_bib63","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev.pharmtox.011008.145638","article-title":"The COXIB experience: a look in the rearview mirror","volume":"49","author":"Marnett","year":"2009","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2026.118781_bib64","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1194\/jlr.R800042-JLR200","article-title":"Cyclooxygenases: structural and functional insights","volume":"50","author":"Rouzer","year":"2009","journal-title":"J. Lipid Res."},{"issue":"10","key":"10.1016\/j.ejmech.2026.118781_bib65","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1107\/S2053230X16014230","article-title":"Crystal structure of rofecoxib bound to human cyclooxygenase-2","volume":"72","author":"Orlando","year":"2016","journal-title":"Structural Biology and Crystallization Communications"},{"issue":"33","key":"10.1016\/j.ejmech.2026.118781_bib66","doi-asserted-by":"crossref","first-page":"22903","DOI":"10.1074\/jbc.274.33.22903","article-title":"Arachidonic acid oxygenation by COX-1 and COX-2: mechanisms of catalysis and inhibition\u2217 210","volume":"274","author":"Marnett","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118781_bib67","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1053\/gast.2001.22432","article-title":"Rofecoxib, a COX-2 inhibitor, does not inhibit human gastric mucosal prostaglandin production","volume":"120","author":"Wight","year":"2001","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.ejmech.2026.118781_bib68","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0002-9343(86)90073-2","article-title":"Prostaglandins, thromboxanes, and leukotrienes in inflammation","volume":"80","author":"Malmsten","year":"1986","journal-title":"Am. J. Med."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118781_bib69","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1172\/JCI116245","article-title":"Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils","volume":"91","author":"Sperling","year":"1993","journal-title":"J. Clin. Investig."},{"issue":"7","key":"10.1016\/j.ejmech.2026.118781_bib70","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1194\/jlr.R068072","article-title":"The discovery and early structural studies of arachidonic acid","volume":"57","author":"Martin","year":"2016","journal-title":"J. Lipid Res."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118781_bib71","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.intimp.2009.02.003","article-title":"Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumour-angiogenesis","volume":"9","author":"Hyde","year":"2009","journal-title":"Int. Immunopharmacol."},{"issue":"24","key":"10.1016\/j.ejmech.2026.118781_bib72","doi-asserted-by":"crossref","first-page":"15559","DOI":"10.1021\/acsomega.1c01952","article-title":"Clarification of arachidonic acid metabolic pathway intricacies","volume":"6","author":"Tallima","year":"2021","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118781_bib73","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.plipres.2010.07.005","article-title":"Old and new generation lipid mediators in acute inflammation and resolution","volume":"50","author":"Stables","year":"2011","journal-title":"Prog. Lipid Res."},{"issue":"5548","key":"10.1016\/j.ejmech.2026.118781_bib74","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: advances in eicosanoid biology","volume":"294","author":"Funk","year":"2001","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.ejmech.2026.118781_bib75","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.3390\/ijms20153683","article-title":"Arachidonic acid metabolism and kidney inflammation","volume":"20","author":"Wang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118781_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb-2004-5-9-241","article-title":"The cyclooxygenases","volume":"5","author":"Chandrasekharan","year":"2004","journal-title":"Genome Biol."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118781_bib77","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0014-5793(98)00657-7","article-title":"Cellular regulation of prostaglandin H synthase catalysis","volume":"430","author":"Kulmacz","year":"1998","journal-title":"FEBS Lett."},{"issue":"12","key":"10.1016\/j.ejmech.2026.118781_bib78","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1096\/fasebj.12.12.1063","article-title":"Cyclooxygenase in biology and disease","volume":"12","author":"Dubois","year":"1998","journal-title":"FASEB J."},{"issue":"13","key":"10.1016\/j.ejmech.2026.118781_bib79","doi-asserted-by":"crossref","first-page":"10347","DOI":"10.1074\/jbc.M009377200","article-title":"Prostaglandin endoperoxide H Synthase-1: the functions of cyclooxygenase active site residues in the binding, positioning, and oxygenation of arachidonic acid\u2217 210","volume":"276","author":"Thuresson","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118781_bib80","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1124\/pr.110.003517","article-title":"International Union of basic and clinical pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress","volume":"63","author":"Woodward","year":"2011","journal-title":"Pharmacol. Rev."},{"issue":"24","key":"10.1016\/j.ejmech.2026.118781_bib81","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM199906173402407","article-title":"Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs","volume":"340","author":"Wolfe","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118781_bib82","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/bcpt.12134","article-title":"Inhibitors of the arachidonic acid cascade: interfering with multiple pathways","volume":"114","author":"Meirer","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118781_bib83","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1586\/eci.09.62","article-title":"Montelukast in the treatment of asthma and beyond","volume":"5","author":"Diamant","year":"2009","journal-title":"Expet Rev. Clin. Immunol."},{"issue":"7","key":"10.1016\/j.ejmech.2026.118781_bib84","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1172\/JCI97946","article-title":"Leukotriene receptors as potential therapeutic targets","volume":"128","author":"Yokomizo","year":"2018","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118781_bib85","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118781_bib86","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2174\/1381612043453144","article-title":"Cyclooxygenase enzymes: regulation and function","volume":"10","author":"Fitzpatrick","year":"2004","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118781_bib87","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4103\/0973-029X.92968","article-title":"Expression of vascular endothelial growth factor and microvessel density in oral tumorigenesis","volume":"16","author":"Astekar","year":"2012","journal-title":"J. Oral Maxillofac. Pathol."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118781_bib88","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.fertnstert.2007.07.1332","article-title":"Expression of cyclooxygenase-2 and vascular endothelial growth factor in ovarian endometriotic cysts and their relationship with angiogenesis","volume":"90","author":"Ceyhan","year":"2008","journal-title":"Fertil. Steril."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118781_bib89","first-page":"518","article-title":"Altered eicosanoid levels in human colon cancer","volume":"122","author":"Rigas","year":"1993","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.ejmech.2026.118781_bib90","series-title":"Seminars in Oncology","article-title":"Cyclooxygenase-2: a potential target in breast cancer","author":"Wang","year":"2004"},{"issue":"3","key":"10.1016\/j.ejmech.2026.118781_bib91","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/hed.20503","article-title":"Inverse correlation between serum PGE2 and T classification in head and neck cancer","volume":"29","author":"Hambek","year":"2007","journal-title":"Head Neck"},{"issue":"5","key":"10.1016\/j.ejmech.2026.118781_bib92","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1074\/jbc.M411221200","article-title":"15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer","volume":"280","author":"Backlund","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.ejmech.2026.118781_bib93","doi-asserted-by":"crossref","first-page":"7818","DOI":"10.1158\/0008-5472.CAN-05-4368","article-title":"15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer","volume":"66","author":"Wolf","year":"2006","journal-title":"Cancer Res."},{"issue":"23","key":"10.1016\/j.ejmech.2026.118781_bib94","doi-asserted-by":"crossref","first-page":"9409","DOI":"10.1073\/pnas.0902367106","article-title":"15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors","volume":"106","author":"Yan","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118781_bib95","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ccr.2004.08.011","article-title":"Prostaglandin E2 promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor \u03b4","volume":"6","author":"Wang","year":"2004","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.ejmech.2026.118781_bib96","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1158\/0008-5472.CAN-07-6100","article-title":"Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis","volume":"68","author":"Nakanishi","year":"2008","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118781_bib97","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1158\/0008-5472.CAN-05-3767","article-title":"Hematopoietic prostaglandin D synthase suppresses intestinal adenomas in Apc Min\/+ mice","volume":"67","author":"Park","year":"2007","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118781_bib98","first-page":"28","article-title":"Involvement of prostaglandin E receptor subtype EP4 in colon carcinogenesis","volume":"62","author":"Mutoh","year":"2002","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118781_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcp.20998","article-title":"Present concepts and future outlook: function of peroxisome proliferator\u2010activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer","volume":"212","author":"Sertznig","year":"2007","journal-title":"J. Cell. Physiol."},{"issue":"50","key":"10.1016\/j.ejmech.2026.118781_bib100","doi-asserted-by":"crossref","first-page":"19069","DOI":"10.1073\/pnas.0607948103","article-title":"Crosstalk between peroxisome proliferator-activated receptor \u03b4 and VEGF stimulates cancer progression","volume":"103","author":"Wang","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118781_bib101","doi-asserted-by":"crossref","DOI":"10.1615\/CritRevEukarGeneExpr.v20.i2.10","article-title":"Tumor necrosis factor-\u03b1 signaling in macrophages","volume":"20","author":"Parameswaran","year":"2010","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.ejmech.2026.118781_bib102","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.3389\/fimmu.2018.01849","article-title":"Tumor necrosis factor receptor-associated factor regulation of nuclear factor \u03baB and mitogen-activated protein kinase pathways","volume":"9","author":"Shi","year":"2018","journal-title":"Front. Immunol."},{"issue":"23","key":"10.1016\/j.ejmech.2026.118781_bib103","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.3390\/ijms20236008","article-title":"Cytokines in inflammatory disease","volume":"20","author":"Kany","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.ejmech.2026.118781_bib104","first-page":"4653","article-title":"Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence","volume":"9","author":"Trikha","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118781_bib105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/vaccines4030022","article-title":"The IL-8\/IL-8R axis: a double agent in tumor immune resistance","volume":"4","author":"David","year":"2016","journal-title":"Vaccines"},{"issue":"9","key":"10.1016\/j.ejmech.2026.118781_bib106","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri.2017.49","article-title":"Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy","volume":"17","author":"Nagarsheth","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118781_bib107","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/ijms20010096","article-title":"Chemokines and chemokine receptors: orchestrating tumor metastasization","volume":"20","author":"Marcuzzi","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118781_bib108","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.critrevonc.2019.02.010","article-title":"Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer","volume":"137","author":"Gonzalez-Avila","year":"2019","journal-title":"Crit. Rev. Oncol.-Hematol."},{"key":"10.1016\/j.ejmech.2026.118781_bib109","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10549-020-05670-x","article-title":"Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival","volume":"182","author":"Joseph","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ejmech.2026.118781_bib110","series-title":"Seminars in Cancer Biology","article-title":"The potential and controversy of targeting STAT family members in cancer","author":"Verhoeven","year":"2020"},{"issue":"4","key":"10.1016\/j.ejmech.2026.118781_bib111","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/carcin\/bgi012","article-title":"Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke","volume":"26","author":"Ye","year":"2005","journal-title":"Carcinogenesis"},{"issue":"11","key":"10.1016\/j.ejmech.2026.118781_bib112","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1093\/carcin\/22.11.1765","article-title":"Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis","volume":"22","author":"Kelavkar","year":"2001","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118781_bib113","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1749-6632.1971.tb53205.x","article-title":"The release of prostaglandins from lung and other tissues","volume":"180","author":"Piper","year":"1971","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3S1","key":"10.1016\/j.ejmech.2026.118781_bib114","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/S0002-9343(97)00203-9","article-title":"Mechanism of action of nonsteroidal anti-inflammatory drugs","volume":"104","author":"Vane","year":"1998","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejmech.2026.118781_bib115","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2165\/00128072-200103110-00004","article-title":"Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol","volume":"3","author":"Litalien","year":"2001","journal-title":"Paediatric drugs"},{"key":"10.1016\/j.ejmech.2026.118781_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114147","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective","volume":"180","author":"Bindu","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118781_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107393","article-title":"Fenamates and ibuprofen as foundational components in the synthesis of innovative, targeted COX-2 anti-inflammatory drugs, undergoing thorough biopharmacological assessments and in-silico computational studies","volume":"147","author":"Elgohary","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2026.118781_bib118","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1365-2036.2007.03292.x","article-title":"Cyclooxygenase\u20102 selectivity of non\u2010steroidal anti\u2010inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident","volume":"25","author":"Abraham","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.ejmech.2026.118781_bib119","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1021\/jm960803q","article-title":"Synthesis and biological evaluation of the 1, 5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1 H-pyrazol-1-yl] benzenesulfonamide (SC-58635, celecoxib)","volume":"40","author":"Penning","year":"1997","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.ejmech.2026.118781_bib120","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0960-894X(99)00288-7","article-title":"The discovery of rofecoxib,[MK 966, VIOXX\u00ae, 4-(4\u2032-methylsulfonylphenyl)-3-phenyl-2 (5H)-furanone], an orally active cyclooxygenase-2 inhibitor","volume":"9","author":"Prasit","year":"1999","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"2","key":"10.1016\/j.ejmech.2026.118781_bib121","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1073\/pnas.97.2.925","article-title":"Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors","volume":"97","author":"Kalgutkar","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118781_bib122","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0022-3565(24)38776-2","article-title":"Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2","volume":"296","author":"Riendeau","year":"2001","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2026.118781_bib123","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejmech.2014.04.045","article-title":"Design and synthesis of novel 2-phenyl-5-(1, 3-diphenyl-1H-pyrazol-4-yl)-1, 3, 4-oxadiazoles as selective COX-2 inhibitors with potent anti-inflammatory activity","volume":"80","author":"Bansal","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2026.118781_bib124","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1161\/CIRCULATIONAHA.113.004480","article-title":"Nonsteroidal anti-inflammatory drugs and the heart","volume":"129","author":"Patrono","year":"2014","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ejmech.2026.118781_bib125","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1001\/jama.286.8.954","article-title":"Risk of cardiovascular events associated with selective COX-2 inhibitors","volume":"286","author":"Mukherjee","year":"2001","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ejmech.2026.118781_bib126","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1002\/jcp.27411","article-title":"Cyclooxygenase\u20102 in cancer: a review","volume":"234","author":"Hashemi Goradel","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"10","key":"10.1016\/j.ejmech.2026.118781_bib127","doi-asserted-by":"crossref","first-page":"8555","DOI":"10.1021\/acsami.8b00875","article-title":"Celecoxib-induced self-assembly of smart albumin-doxorubicin conjugate for enhanced cancer therapy","volume":"10","author":"Shi","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejmech.2026.118781_bib128","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2017.04.025","article-title":"The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancer","volume":"400","author":"Brizzolara","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2026.118781_bib129","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s005350200151","article-title":"Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines","volume":"37","author":"Noda","year":"2002","journal-title":"J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118781_bib130","doi-asserted-by":"crossref","first-page":"6074","DOI":"10.1038\/s41598-017-06253-5","article-title":"Paracrine cyclooxygenase-2 activity by macrophages drives colorectal adenoma progression in the Apc Min\/+ mouse model of intestinal tumorigenesis","volume":"7","author":"Hull","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118781_bib131","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ajpath.2017.10.025","article-title":"The presence of cyclooxygenase 2, tumor-associated macrophages, and collagen alignment as prognostic markers for invasive breast carcinoma patients","volume":"188","author":"Esbona","year":"2018","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118781_bib132","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1200\/JCO.2005.09.112","article-title":"Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention","volume":"23","author":"Dannenberg","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118781_bib133","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.drudis.2016.09.017","article-title":"Cyclooxygenase-2 in glioblastoma multiforme","volume":"22","author":"Qiu","year":"2017","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118781_bib134","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1054\/bjoc.2000.1119","article-title":"Nested case\u2013control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage","volume":"83","author":"Sharpe","year":"2000","journal-title":"Br. J. Cancer"},{"issue":"8","key":"10.1016\/j.ejmech.2026.118781_bib135","first-page":"2101","article-title":"Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor","volume":"60","author":"Harris","year":"2000","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.ejmech.2026.118781_bib136","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1158\/1078-0432.CCR-17-2725","article-title":"COX-2\/PGE2 axis regulates HIF2\u03b1 activity to promote hepatocellular carcinoma hypoxic response and reduce the sensitivity of sorafenib treatment","volume":"24","author":"Dong","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118781_bib137","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1158\/1535-7163.MCT-16-0818","article-title":"COX-2\/sEH dual inhibitor PTUPB potentiates the antitumor efficacy of cisplatin","volume":"17","author":"Wang","year":"2018","journal-title":"Mol. Cancer Therapeut."},{"issue":"14","key":"10.1016\/j.ejmech.2026.118781_bib138","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1200\/JCO.2003.07.127","article-title":"Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non\u2013small-cell lung cancer","volume":"21","author":"Altorki","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2026.118781_bib139","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.oraloncology.2016.03.010","article-title":"Up-regulation of HB-EGF by the COX-2\/PGE2 signaling associates with the cisplatin resistance and tumor recurrence of advanced HNSCC","volume":"56","author":"Yang","year":"2016","journal-title":"Oral Oncol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118781_bib140","doi-asserted-by":"crossref","DOI":"10.1634\/theoncologist.2017-0474","article-title":"Phase II trial using a combination of oxaliplatin, capecitabine, and celecoxib with concurrent radiation for newly diagnosed resectable rectal cancer","volume":"23","author":"Araujo\u2010Mino","year":"2018","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.ejmech.2026.118781_bib141","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.2174\/138945011795677764","article-title":"Biology of Cox-2: an application in cancer therapeutics","volume":"12","author":"Khan","year":"2011","journal-title":"Curr. Drug Targets"},{"issue":"8","key":"10.1016\/j.ejmech.2026.118781_bib142","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1021\/acs.biochem.5b01378","article-title":"Crystal structure of aspirin-acetylated human cyclooxygenase-2: insight into the formation of products with reversed stereochemistry","volume":"55","author":"Lucido","year":"2016","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118781_bib143","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4255\/mcpharmacol.09.05","article-title":"Anti-inflammatory agents for cancer therapy","volume":"1","author":"Rayburn","year":"2009","journal-title":"Mol. Cell. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118781_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.137787","article-title":"Azole rings linked to COX inhibitors via hydrazone bridge: Synthesis, stereochemical analysis, and investigation of antimicrobial activity","volume":"1306","author":"Karag\u00fczel","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"8","key":"10.1016\/j.ejmech.2026.118781_bib145","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.bmc.2004.01.037","article-title":"Design, synthesis and biological evaluation of some pyrazole derivatives as anti-inflammatory-antimicrobial agents","volume":"12","author":"Bekhit","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118781_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117499","article-title":"Unveiling a novel pyrazolopyrimidine scaffold as a dual COX-2\/5-LOX inhibitor with immunomodulatory potential: design, synthesis, target prediction, anti-inflammatory activity, and ADME-T with docking simulation","volume":"290","author":"Ragab","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118781_bib147","article-title":"Synthesis and in silico studies of novel thiophene\u2013celecoxib hybrid with excellent cardiotoxicity and nephrotoxicity safety profiles","author":"Abdelall","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118781_bib148","article-title":"Design, synthesis, in silico analysis, anti-inflammatory, and cytotoxicity evaluation of novel formyl-pyrazoline derivatives","author":"Nayak","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2026.118781_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112066","article-title":"Design, synthesis and biological evaluation of novel pyrazole sulfonamide derivatives as dual COX-2\/5-LOX inhibitors","volume":"189","author":"Gedawy","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118781_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104418","article-title":"Synthesis of novel halogenated triarylpyrazoles as selective COX-2 inhibitors: anti-inflammatory activity, histopatholgical profile and in-silico studies","volume":"105","author":"Abdellatif","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118781_bib151","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.52711\/0974-360X.2024.00243","article-title":"Bis-mannich base derivatives of curcumin pyrazole: synthesis and its anti-inflammatory study In-vitro and In-silico","volume":"17","author":"Aryati","year":"2024","journal-title":"Res. J. Pharm. Technol."},{"key":"10.1016\/j.ejmech.2026.118781_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115138","article-title":"Development of novel pyrazole, imidazo [1, 2-b] pyrazole, and pyrazolo [1, 5-a] pyrimidine derivatives as a new class of COX-2 inhibitors with immunomodulatory potential","volume":"249","author":"Ayman","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118781_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105068","article-title":"Investigation of indole functionalized pyrazoles and oxadiazoles as anti-inflammatory agents: synthesis, in-vivo, in-vitro and in-silico analysis","volume":"114","author":"Kumar","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118781_bib154","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0223-5234(00)00150-1","article-title":"The pyrrole moiety as a template for COX-1\/COX-2 inhibitors","volume":"35","author":"Dannhardt","year":"2000","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118781_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140027","article-title":"Structure-Activity relationship of 5-butyl-4,6-dimethyl-2-{[4-(o-fluorophenyl)-1-piperazinyl]-2-oxoethyl}-pyrrolo[3,4-c]pyrrole-1,3(2H,5H)-dione: An experimental and theoretical study","volume":"1322","author":"Redzicka","year":"2025","journal-title":"J. Mol. Struct."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118781_bib156","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1039\/D3RA07078F","article-title":"Design, synthesis, pharmacological evaluation, and in silico studies of the activity of novel spiro pyrrolo [3, 4-d] pyrimidine derivatives","volume":"14","author":"Alzahrani","year":"2024","journal-title":"RSC Adv."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118781_bib157","first-page":"1983","article-title":"Systematic review on thiazole and its applications","volume":"30","author":"Tyagi","year":"2024","journal-title":"Educational Administration: Theor. Pract."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118781_bib158","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1080\/14756360802519558","article-title":"Synthesis of 4-benzyl-1, 3-thiazole derivatives as potential anti-inflammatory agents: an analogue-based drug design approach","volume":"24","author":"Sharma","year":"2009","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118781_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140081","article-title":"Synthesis, structural, DFT studies, biological effectiveness, and molecular docking aspects of multitarget novel N-(4-Phenylthiazol-2-yl) hydrazine carboxamide hybrids as COX inhibitors, Anti-TB, and Anti-oxidant activity","volume":"1321","author":"Hiremath","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2026.118781_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.139393","article-title":"Targeting inflammation through inhibition of COX-2 by substituted 4-thiazolidinone analogues: in-vitro, in-vivo and in-silico studies","volume":"1319","author":"Singh","year":"2025","journal-title":"J. Mol. Struct."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118781_bib161","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13065-023-00924-3","article-title":"Design, synthesis, molecular docking studies and biological evaluation of thiazole carboxamide derivatives as COX inhibitors","volume":"17","author":"Hawash","year":"2023","journal-title":"BMC Chem."},{"issue":"32","key":"10.1016\/j.ejmech.2026.118781_bib162","doi-asserted-by":"crossref","first-page":"29512","DOI":"10.1021\/acsomega.3c03256","article-title":"New thiazole carboxamide derivatives as COX inhibitors: design, synthesis, anticancer screening, in silico molecular docking, and ADME profile studies","volume":"8","author":"Hawash","year":"2023","journal-title":"ACS Omega"},{"issue":"4","key":"10.1016\/j.ejmech.2026.118781_bib163","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2174\/0118715230296273240725065839","article-title":"In-silico based designing of benzo [d] thiazol-2-amine derivatives as analgesic and Anti-inflammatory agents","volume":"23","author":"Mishra","year":"2024","journal-title":"Anti-Inflammatory Anti-Allergy Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118781_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104890","article-title":"Design, synthesis, and biological evaluation of new pyrimidine-5-carbonitrile derivatives bearing 1, 3-thiazole moiety as novel anti-inflammatory EGFR inhibitors with cardiac safety profile","volume":"111","author":"Abdel-Aziz","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118781_bib165","article-title":"Identification and development of thiazole leads as COX-2\/5-LOX inhibitors through in-vitro and in-vivo biological evaluation for anti-inflammatory activity","volume":"100","author":"Manju","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118781_bib166","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13065-020-00730-1","article-title":"Synthesis and therapeutic potential of imidazole containing compounds","volume":"15","author":"Siwach","year":"2021","journal-title":"BMC Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118781_bib167","article-title":"Design, synthesis, and biological evaluation of novel imidazole derivatives as analgesic and anti-inflammatory agents: experimental and molecular docking insights","volume":"14","author":"Muheyuddeen","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118781_bib168","first-page":"255","article-title":"Synthesis, molecular docking, and anti-inflammatory activities of some novel benzimidazole derivatives as potential Cyclo-oxygenase-2 inhibitors","volume":"67","author":"Elrayess","year":"2024","journal-title":"Egypt. J. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118781_bib169","doi-asserted-by":"crossref","first-page":"239","DOI":"10.21608\/bfsa.2023.300941","article-title":"Synthesis, biological evaluation and molecular docking of diarylimidazole derivatives as new potential anti-inflammatory agents targeting COX-2 enzyme","volume":"46","author":"Ghanim","year":"2023","journal-title":"Bulletin of Pharmaceutical Sciences Assiut University"},{"issue":"3","key":"10.1016\/j.ejmech.2026.118781_bib170","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3390\/ph15030282","article-title":"Drug discovery of new anti-inflammatory compounds by targeting cyclooxygenases","volume":"15","author":"Burayk","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2026.118781_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131652","article-title":"Design, synthesis and biological evaluation of new imidazo [1, 2-a] pyridine derivatives as selective COX-2 inhibitors","volume":"1250","author":"Ismael","year":"2022","journal-title":"J. Mol. Struct."},{"issue":"44","key":"10.1016\/j.ejmech.2026.118781_bib172","doi-asserted-by":"crossref","first-page":"27659","DOI":"10.1039\/D1RA04756F","article-title":"Design, synthesis, biological assessment and in silico ADME prediction of new 2-(4-(methylsulfonyl) phenyl) benzimidazoles as selective cyclooxygenase-2 inhibitors","volume":"11","author":"Badawy","year":"2021","journal-title":"RSC Adv."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118781_bib173","doi-asserted-by":"crossref","first-page":"289","DOI":"10.32383\/appdr\/118364","article-title":"Novel aryl\/alkyl azole derivates as an anti-nociceptive and anti-inflammatory drug candidates","volume":"77","author":"Kaya-Yasar","year":"2020","journal-title":"Acta Poloniae Pharmaceutica-Drug Research"},{"key":"10.1016\/j.ejmech.2026.118781_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.132741","article-title":"Synthesis, analgesic, anti-inflammatory, COX\/5-LOX inhibition, ulcerogenic evaluation, and docking study of benzimidazole bearing indole and benzophenone analogs","volume":"1259","author":"Nagesh","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2026.118781_bib175","series-title":"Heterocyclic Anti-inflammatory Agents: a Guide for Medicinal Chemists","first-page":"70","article-title":"Isoxazoline and oxazoline derivatives as anti-inflammatory agents","author":"Sharma","year":"2024"},{"key":"10.1016\/j.ejmech.2026.118781_bib176","first-page":"217","article-title":"Design, molecular docking, synthesis, preliminary in silico ADME studies, and anti-inflammatory evaluation of new oxazole derivatives","author":"Amer","year":"2022","journal-title":"J. Pharm. Negat. Results"},{"key":"10.1016\/j.ejmech.2026.118781_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.152998","article-title":"Microwave-assisted green synthesis of novel Benzoxazole\/benzothiazole-pyrazole hybrids with potential anti-inflammatory, anti-tubercular, and antimicrobial properties","author":"Kokane","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2026.118781_bib178","article-title":"Synthesis, analgesic, anti-inflammatory, ulcerogenic evaluation, and docking study of (benzoylphenoxy)-N-{5-[2-methylphenyl-6-chlorobenzoxazole]} acetamides as COX\/5-LOX inhibitor","volume":"1272","author":"Khadri","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2026.118781_bib179","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2024.106478","article-title":"Design, synthesis and molecular docking of novel D-ring substituted steroidal 4, 5-dihydropyrazole thiazole derivatives that act as iNOS\/COX-2 inhibitors with potent anti-inflammatory activity against LPS-induced RAW264. 7 macrophage cells","volume":"240","author":"Fang","year":"2024","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejmech.2026.118781_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116460","volume":"272","author":"Cai","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118781_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104883","article-title":"Design, synthesis, biological evaluation, and computational studies of novel thiazolo-pyrazole hybrids as promising selective COX-2 inhibitors: implementation of apoptotic genes expression for ulcerogenic liability assessment","volume":"111","author":"Marzouk","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118781_bib182","doi-asserted-by":"crossref","first-page":"107372","DOI":"10.1016\/j.bioorg.2024.107372","article-title":"Discovery of new 2-(3-(naphthalen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)thiazole derivatives with potential analgesic and anti-inflammatory activities: In vitro, in vivo and in silico investigations","volume":"147","author":"Mohammed","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2026.118781_bib183","article-title":"Pharmacological investigations of newly synthesized oxazolones and imidazolones as COX-2 inhibitors","volume":"32","author":"Babari","year":"2024","journal-title":"Saudi Pharm. J."},{"issue":"7","key":"10.1016\/j.ejmech.2026.118781_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115403","article-title":"Novel class of benzimidazole-thiazole hybrids: the privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes","volume":"28","author":"Maghraby","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118781_bib185","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106273","article-title":"Novel pyrazole-based COX-2 inhibitors as potential anticancer agents: design, synthesis, cytotoxic effect against resistant cancer cells, cell cycle arrest, apoptosis induction and dual EGFR\/Topo-1 inhibition","volume":"131","author":"Halim","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118781_bib186","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117340","article-title":"Optimization of pyrazole\/1, 2, 4-triazole as dual EGFR\/COX-2 inhibitors: design, synthesis, anticancer potential, apoptosis induction and cell cycle analysis","author":"Kahk","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118781_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105302","article-title":"Novel 1, 5-diaryl pyrazole-3-carboxamides as selective COX-2\/sEH inhibitors with analgesic, anti-inflammatory, and lower cardiotoxicity effects","volume":"116","author":"Hendawy","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118781_bib188","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104096","article-title":"Discovery of novel aminophosphonate derivatives containing pyrazole moiety as potential selective COX-2 inhibitors","volume":"102","author":"Zhang","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118781_bib189","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000116","article-title":"Design and synthesis of pyrazole\u2013pyrazoline hybrids as cancer\u2010associated selective COX\u20102 inhibitors","volume":"354","author":"Akhtar","year":"2021","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.ejmech.2026.118781_bib190","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.109081","article-title":"Pioneering 1, 3, 5-triaryl pyrazolines as promising dual inhibitors of COX-2 and 15-LOX endowed with potent anticancer activity: design, synthesis, and in silico study","volume":"166","author":"Abdullah","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118781_bib191","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1021\/acs.jmedchem.5c02815","article-title":"Design, synthesis, and evaluation of organic and organometallic pyrazoline derivatives as selective dual COX-2\/5-LOX inhibitors and potential anticancer agents","volume":"69","author":"Navarrete","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118781_bib192","article-title":"Pyrazole derivatives as dual COX-2\/EGFR inhibitors with anticancer potential: optimization of difenamizole analogs","author":"Farag","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2026.118781_bib193","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1039\/C7MD00067G","article-title":"Imidazoles as potential anticancer agents","volume":"8","author":"Ali","year":"2017","journal-title":"Medchemcomm"},{"issue":"5","key":"10.1016\/j.ejmech.2026.118781_bib194","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s00044-023-03041-x","article-title":"Design, synthesis, and biological evaluation of new 2-(4-(methylsulfonyl)phenyl)-N-phenylimidazo[1,2-a]pyridin-3-amine as selective COX-2 inhibitors","volume":"32","author":"Movahed","year":"2023","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2026.118781_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108962","article-title":"Indole-imidazolone derivatives as dual Mcl-1\/COX-2 inhibitors: design-oriented synthesis, molecular docking, and dynamics studies with potential anticancer and anti-inflammatory activities","author":"Lamie","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118781_bib196","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103007","article-title":"Recent advancement in the discovery and development of COX-2 inhibitors: insight into biological activities and SAR studies (2008\u20132019)","volume":"89","author":"Sharma","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118781_bib197","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202103559","article-title":"Synthesis, biological evaluation and in silico studies of some 2\u2010substituted benzoxazole derivatives as potential anticancer agents to breast cancer","volume":"7","author":"Kuzu","year":"2022","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2026.118781_bib198","article-title":"Click-modifiable isatin hydrazones as COX-2, VEGFR-2, and carbonic anhydrase inhibitors: a multi-target approach to cancer therapy","author":"El-Attar","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118781_bib199","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133141","article-title":"Novel therapeutic heterocycles as selective cyclooxygenase-2 inhibitors and anti-cancer agents: synthesis, in vitro bioassay screenings, and molecular docking studies","volume":"1263","author":"El-Barghouthi","year":"2022","journal-title":"J. Mol. Struct."},{"issue":"13","key":"10.1016\/j.ejmech.2026.118781_bib200","first-page":"141","article-title":"A review: biological importance of heterocyclic compounds","volume":"9","author":"Al-Mulla","year":"2017","journal-title":"Der Pharma Chem"},{"issue":"3","key":"10.1016\/j.ejmech.2026.118781_bib201","first-page":"66","article-title":"A review: biological significances of heterocyclic compounds","volume":"4","author":"Saini","year":"2013","journal-title":"Int. J. Pharma Sci. Res."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118781_bib202","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12967-017-1150-7","article-title":"COX-2 expression positively correlates with PD-L1 expression in human melanoma cells","volume":"15","author":"Botti","year":"2017","journal-title":"J. Transl. Med."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426002266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426002266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T06:24:58Z","timestamp":1776147898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426002266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":202,"alternative-id":["S0223523426002266"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118781","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COX-2 inhibitors in inflammation and cancer: Recent developments in medicinal chemistry","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118781","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118781"}}